Thank you for your submission to EMBO reports and please accept my apology for the time it has taken me to contact you with a decision on your manuscript. We have now received the enclosed reports from the three referees that were asked to assess your study. As you will see, referees 1 and 3 are quite positive, whereas referee 2 believes that the manuscript should develop ideas on the mechanisms of prion mutability, as otherwise it would be more suitable to a specialized journal. Given that s/he provides good ideas on how to develop the study further, I think it would be productive to invite revision of your study at this stage.
In this case, I feel it would be particularly important to address referee 2's concerns in full, as this will provide a more significant conceptual advance and be more accessible to the general readership of the journal. In addition, the characterization of the prion clones requested by referee 1 and addressing the clarifications requested by all referees would also benefit the study. Once the referee concerns are adequately addressed, we would be happy to accept your manuscript for publication. Please note that it is EMBO reports policy to undergo one round of revision only and thus, acceptance of your study will depend on how the referee concerns have been addressed in next, final version of the manuscript. I look forward to seeing a revised form of your manuscript when it is ready. In the meantime, do not hesitate to get in touch with me if I can be of any assistance.
Yours sincerely,

Editor EMBO Reports
REFEREE REPORTS:
Referee #1:
The manuscript by Jiali Li et al. is an interesting study into the potential influence of cellular factors on 'mutability' of murine prions in a different environment. The Authors described and characterized the effects of swainsonine (swa) in conferring resistance and competence to murine prion replication in prion-infected cell lines. They show that swa-sensitive prions propagated in PK1 cells and unable to develop swa resistance in the initial cloning phase shifted into swa-competent prions after serial propagation. They also show that one clone remained swa incompetent even after many passages in culture; surprisingly, this apparently immutable clone, after propagation in brain, gave rise to swaresistant prions, indistinguishable from the original 22L population. The main conclusion is that prion 'mutability' is a sub strain-specific trait.
The study is straightforward and sound. However, data showing the effect of swa on band shift on Western blot should be included in order to determine whether the swa effect is not an artifact due to differential levels of sugars in specific clones and sub clones. Swainsonine, an indolizidine alkaloid inhibits the processing of asparagine-linked glycoproteins (inhibits α-mannosidase II in glycoprotein processing and leads to increased high mannose oligosaccharides). It was previously shown that removing high mannose with endoglycosidase H resulted in the conversion of 28-and 33 kDa bands into a 26 kDa band, providing some evidence that the 28-and 33 kDa bands had differing amounts of high mannose glycans. Furthermore, previous work demonstrated that PrPC and PrPSc contain different but overlapping sets of glycan structures. The cause of the shift remains unknown, but it was suggested that this results from the alteration of a glycan processing enzyme in cells producing PrPSc. Non-infected clones should also be measured for levels of sugars to determine whether the initial starting levels had any effect on protein conformation and if these levels are being restored downstream following propagation and sub cloning or re-infection with brain homogenates.
Referee #2:
As the paper currently stands the manuscript would be more suitable for a more specialised journal. However if the authors are prepared to develop ideas around mechanisms of prion mutability it might become appropriate for publication in EMBO Reports.
The manuscript by Li et al., entitled "Mutability of prions" reports about the ability of prion strains to be highly mutable in different environments (cells and brain) and related to the use of a drug (swa).
The prion concept of a protein as infectious agent with presence of different strains of disease is unique and novel in the infectious diseases field. Previous work by the authors has shown that a biological cloned prion strain can become heterogeneous and mutate under selective in vitro pressure and revert to the original strain upon inoculation in the brain(Li et al., Science 2010). This new work is an extension of previous published work by the same authors. In this case they have further propagated five cloned populations that did not mutate in the authors' previous work (Li et al., Science 2010) . Now, by propagating these five clones for much longer in their cell culture system and using also a new isolate the authors are here suggesting that the mutational ability of prions is actually surprisingly more complex than expected. Indeed, as clearly shown in Figure 1 , three different classes of substrains emerged according to their ability/inability to be swa resistant in PK1 cells suggesting the presence of many mutants of the same strain. Some of these strains eventually mutated whereas another one remained stable even after many doublings. When these mutants were inoculated back into mice, the original brain-linked properties re-emerged as shown previously on a more limited panel of mutants.
Please find below specific comments for the authors. 1) Because this manuscript aims for a wide range audience some concepts may not be clear for scientists outside the prion field or not familiar with this type of work. Some concepts like strain vs. substrain, should be explained in more detail .The technique used in the Results section should be described in more detail to allow interpretation of Figures 2-4. It is also not very clear what R33 cells are (page 4). 2) Have the authors an explanation on why clones #5 and 6 remained doubtful? Highly mutable clones? Failure of the test? Low infectious titres? Other? Can the author comment on this issue in the manuscript? 3) From the studies both presented here and in previous publications, a strong influence of the environment in selecting the clones emerges. One of the most obvious players for this effect is host PrP. Although both cells and brains used in this study express the murine PrP, some differences in terms of genotype (e.g. codons 108/189) may be present between the two hosts. Have the authors checked if the PrP expressed in the cells and in the brain are similar in terms of genotype? Is this something that the authors think could have an impact on the selection and/or emergence of the new substrains? 4) In previous publications the group included a line in the graphs showing the threshold for positivity. In the figures presented with this new work the authors should considering inclusion of such marker to allow better interpretation of the data 5) In figure 4 the red a blue codes have presumably the same meaning of the ones in Figure 2 . However this is not clear and it should be mentioned in the legend.
The present manuscript is an interesting extension of the authors previous work demonstrating the complexity of mutation of prion strains. A discussion of possible mechanisms underlining this complexity would benefit the discussion of the manuscript and provide new and testable hypotheses to understand the mutability of prions.
Referee #3:
Review of the manuscript titled "Mutability of prions" by Jiali Li, Sukhvir P.Mahal, Cheryl A. Demczyk & Charles Weissmann.
Comments:
The authors developed powerful method called Cell Panel Assay (CPA), which characterizes murine strains of prions by their relative capacity to replicate in a panel of cloned cell lines (Mahal et al, 2007) . Using this method, they studied in this paper sensitivity of 22L murine prions to glycosylation modifier swainsonine (swa) and potency to infect unique cloned cell lines during large number of serial passages. While mice brain-derived 22L prions are swa-resistant, PK1 cell-adapted 22L prion populations become swa sensitive. After serial propagation for 30 to 90 doublings, 4 of 9 clones became swa competent, indicating emergence of swa-resistant "mutants" during replication. One clone remained swa incompetent even after 1035-fold expansion. Surprisingly, this apparently immutable clone reverted to swa-resistant prions after propagation in the brain. This paper is an important extension of the previous observation, in which this group uncovered Darwinian evolution of prions in cell culture (Li et al., Science 2010) . In this report, the authors concluded that cell-adapted 22L prions assumed either mutable or virtually immutable conformations that in the brain became mutable again and thus the mutability is a substrain-specific attribute. Therefore, the PrPSc can adopt not only swa-sensitive and swa-resistant conformations, but also conformations that show different degrees of passage-to-passage stability. The prion "mutations" described in this paper may offer new insight into the molecular mechanisms involved in replication of the misfolded proteins that drive prion transmission, propagation, and host adaptability. This is an interesting paper supported by large volume of data that will require some modifications before publication.
Specific comments: 1. The use of Swa, an inhibitor of α-mannosidase II causing misglycosylation of N-linked glycans, could lead the reader not familial with the previous papers to the conclusion that the described effects are caused by change in the glysosylation or charge of PrPC, and not by change in the conformation of PrPSc. The link between Swa and conformation of PrPSc should be stressed and better explained in the Abstract and elsewhere. 2. The headings in the Table 2 have to be replaced with descriptive terms that can be understood by general reader. The operations and symbols that are currently in the headings of column 5 and 6 of Table 2 have to be described, explained, and justified in the Methods, Legend, or alternatively in the Supplement.
3. It is difficult to understand the data on brain homogenate (Brain[22L] , first raw) in Table 3 . Is the {plus minus} 93% value standard deviation or S.E.M? On how many experiments (n) are the data in the table based on? Assuming Gaussian distribution, such a large error rate would suggest some 0 or negative values. How it would be possible? This has to be commented on and explained in the Results. 4. There are some overlaps between Introduction and Discussion section that should be eliminated or modified. Response to Referee #1:
-The …. data showing the effect of swa on band shift on Western blot should be included in order to determine whether the swa effect is not an artifact due to differential levels of sugars in specific clones and sub clones.
-In Supp. Fig. 1 we show the western blots of the 9 cloned prion populations -We have also seen that swa causes the same misglycosylation in LD9 cells and PK1 cells, but only PK1 cells show a swa effect (Browning et al., submitted).
-In Supp. Fig. 2 we show that a swa sensitive clone (C10) rendered swa resistant by prolonged exposure to swa (S10) show unchanged western blots -Furthermore, previous work demonstrated that PrP C and PrP Sc contain different but overlapping sets of glycan structures. The cause of the shift remains unknown, but it was suggested that this results from the alteration of a glycan processing enzyme in cells producing PrP Sc .
-We believe that this finding more likely reflects the selection of subsets of PrP C when PrPSc is formed, but this is not relevant to this paper. Note also in this connection that PrPSc from different strains gives different glycosylation patterns in the same cell line ( for example, Manuelidis L et al. J Cell Biochem. 2009 :106:220-31.) .
-Non-infected clones should also be measured for levels of sugars to determine whether the initial starting levels had any effect on protein conformation and if these levels are being restored downstream following propagation and sub cloning or re-infection with brain homogenates.
-I am sorry, but I do not understand this suggestion From the studies both presented here and in previous publications, a strong influence of the environment in selecting the clones emerges. One of the most obvious players for this effect is host PrP. Although both cells and brains used in this study express the murine PrP, some differences in terms of genotype (e.g. codons 108/189) may be present between the two hosts. Have the authors checked if the PrP expressed in the cells and in the brain are similar in terms of genotype? Is this something that the authors think could have an impact on the selection and/or emergence of the new substrains? Yes, PrP cDNA has been sequenced for PK1 and R33 cells (C.Baker and S.Browning in our lab) the sequences are identical to those of in the C57BL/6 mouse (Prnp-a) (l. 207-208; l.280-281) 
4)
In previous publications the group included a line in the graphs showing the threshold for positivity. In the figures presented with this new work the authors should considering inclusion of such marker to allow better interpretation of the data The lines do not indicate a threshold for infectivity, they indicate an arbitrary percentage of positive cells at which level we determine the Response Index (RI). As the RI does not play a role in this paper we have not indicated it.
5)
In figure 4 the red a blue codes have presumably the same meaning of the ones in Figure 2 . However this is not clear and it should be mentioned in the legend. Explanation has been added to the legends (l. 384; 392)
The present manuscript is an interesting extension of the authors previous work demonstrating the complexity of mutation of prion strains. A discussion of possible mechanisms underlining this complexity would benefit the discussion of the manuscript and provide new and testable hypotheses to understand the mutability of prions. We have added a paragraph and a figure (1B) with a conjectured mechanism for prion mutation (l.
157-161)
Referee #3:
